Pharmacological Interventions

The use of medication to manage withdrawal symptoms, reduce cravings, or treat co-occurring mental health disorders e.g., methadone, buprenorphine, naltrexone. 

The Health and Social Effects of Nonmedical Cannabis Use

Book
Foreword Cannabis is globally the most commonly used psychoactive substance under international control. In 2013, an estimated 181.8 million people aged 15-64 years used cannabis for nonmedical purposes globally (UNODC, 2015). There is an...

The Role of Adenosine Receptors in Psychostimulant Addiction

Scientific article
 - 
Adenosine receptors (AR) are a family of G-protein coupled receptors, comprised of four members, named A1, A2A, A2B, and A3 receptors, found widely distributed in almost all human body tissues and organs. To date, they are known to...

No Clear Role for Medications in Less Dependent Drinkers

Scientific article
 - 
In 2013 nalmefene was authorised for moderating drinking among patients not in need of detoxification, extending pharmacotherapy to less dependent drinkers. Though uniquely authorised for this purpose, this review found other (and probably...

Novel Vaccines against Morphine Heroin

Scientific article
SUMMARY Drug addiction is one of the most important health problems worldwide. This pathology results in the death of about 500,000 individuals annually around the globe. Despite this scenario, the development of effective drug therapies...